Pictet Asset Management’s Idexx Laboratories IDXX Stock Holding History

Pictet Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128M	Sell	242,507 -45,430	-16%	-$25.5M	0.12%	188
2026 Q1	$162M	Buy	287,937 +115,698	+67%	+$74.2M	0.17%	147
2025 Q4	$117M	Sell	172,239 -107,248	-38%	-$73M	0.11%	196
2025 Q3	$179M	Sell	279,487 -50,874	-15%	-$30.9M	0.17%	140
2025 Q2	$177M	Sell	330,361 -126,005	-28%	-$60.3M	0.18%	133
2025 Q1	$192M	Buy	456,366 +13,882	+3%	+$6.03M	0.21%	119
2024 Q4	$183M	Buy	442,484 +83,964	+23%	+$36.8M	0.2%	130
2024 Q3	$181M	Buy	358,520 +69,102	+24%	+$33.6M	0.2%	135
2024 Q2	$141M	Buy	289,418 +5,293	+2%	+$2.66M	0.16%	153
2024 Q1	$153M	Sell	284,125 -12,540	-4%	-$6.85M	0.17%	156
2023 Q4	$165M	Sell	296,665 -65,235	-18%	-$30.6M	0.18%	143
2023 Q3	$158M	Buy	+361,900	New	+$180M	0.2%	140

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Pictet Asset Management's IDXX Position: Q2 2026 in Review

Pictet Asset Management reduced its Idexx Laboratories (IDXX) stake by 16% in Q2 2026, selling an estimated $25.5M and leaving 242,507 shares worth $128M. The position accounts for 0.12% of the portfolio, ranked #188.

Pictet Asset Management first reported a position in IDXX in Q3 2023 and has held it in 12 quarters since. The position peaked at $192M in Q1 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Pictet Asset Management held 242,507 shares of Idexx Laboratories worth $128M as of Q2 2026.
Pictet Asset Management sold 45,430 Idexx Laboratories shares in Q2 2026, an estimated $25.5M.
Idexx Laboratories made up 0.12% of Pictet Asset Management's portfolio in Q2 2026, its #188 holding.
Pictet Asset Management first reported a position in Idexx Laboratories in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's Idexx Laboratories position peaked at $192M in Q1 2025.
1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.